With fentanyl use increasing in opioid use disorder and stimulant use disorder populations, treatment with suboxone in outpatient settings is becoming more complex. This panel will discuss the latest evidence-based recommendations and the practical experience best practices of the panel and audience members. The objective is for everyone in the room to learn from each other and take new knowledge and ideas back to their patients.

Upon completion of this presentation, participants will be able to:

1. Present considerations of suboxone and related agents in non-acute settings such as primary care, jails, and outpatient clinics; and,

2. Provide practical interventions for high dose buprenorphine, fentanyl inductions, meth delivery and transitions along with other pharma transitions, severe precipitated withdrawal management and other areas related to suboxone in today’s world.